Potential Ban on Menthol Cigarettes in the US

Jul.05.2022
Potential Ban on Menthol Cigarettes in the US
A proposed ban on menthol-flavored tobacco products in the US could result in 16,250 fewer tobacco-related deaths by 2060.

In April of last year, the US Food and Drug Administration (FDA) announced a proposed ban on menthol-flavored cigarettes and cigars. This was seen as a measure that could significantly reduce smoking rates.


A recent study published in the BMJ Tobacco Control has concluded that a ban on menthol cigarettes could prevent 16,250 tobacco-related deaths annually by 2060. Epidemiology professor Rafael Meza from the University of Michigan School of Public Health stated that "This work is part of a series of projects aimed at evaluating the impact of a menthol ban on smoking and health. Our findings demonstrate significant health benefits from a menthol ban and emphasize the urgency of its eventual approval and implementation.


The investigation results were based on an analysis of compiled data and computational modeling infrastructure from a portion of the Tobacco Regulatory Science Center. The research team utilized traditional cigarette and electronic cigarette models, which were previously developed simulation models, to study the impact of menthol and non-menthol cigarettes on the behavior of traditional cigarettes and e-cigarettes.


A new study has found that with a ban on menthol cigarettes, the combined smoking of both menthol and non-menthol cigarettes will decrease by 15% by 2026. The study also predicts a decrease in smoking and e-cigarette related deaths by approximately 5%. This reduction in deaths would result in a decrease of 16,250 deaths per year over the course of 40 years.


As such, the FDA has recently announced a ban on menthol, which has been a topic of long-standing debate. The negotiation process has been opened, and comments will be accepted until July 5th.


Canada's Ban on Menthol Cigarettes


Data from Canada shows that a local ban on menthol cigarettes has had a positive impact on smoking cessation rates. Research suggests that, given the popularity of menthol cigarettes in the United States, implementing a similar ban in that country would provide even greater benefits. According to Geoffrey Fong, Chief Investigator of the International Tobacco Control Policy Evaluation Project, "Based on our survey results, we estimate that a ban on menthol cigarettes in the US would lead to an additional 923,000 smokers quitting, including 230,000 African American smokers.


Further data confirms the effectiveness of the ban on menthol cigarettes.


Meanwhile, a recent study published in JAMA Internal Medicine found that the ban on menthol-flavored cigarettes in Massachusetts resulted in a statewide decrease in cigarette sales. The study, titled "Massachusetts' Cigarette Sales and Comprehensive Menthol Ban," reported that after the menthol flavor ban went into effect, cigarette sales in Massachusetts dropped by as much as 33%.


According to researchers, during the same period, cigarette sales decreased by 8% in 33 states that did not implement a ban on menthol flavoring, while sales of menthol-flavored cigarettes decreased by 3%. UPI quoted Samuel Asare, co-author of the Sid study, as saying, "We have learned from Massachusetts that the ban on menthol flavoring effectively reduced sales of menthol and overall cigarettes.


This article has been compiled from third-party information for the purpose of educational exchange. The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

RLX Technology 2025 Revenue Rises 44.0% YoY to Nearly USD 566.1 million, International Business Accounts for 76.5% in Q4
RLX Technology 2025 Revenue Rises 44.0% YoY to Nearly USD 566.1 million, International Business Accounts for 76.5% in Q4
RLX Technology Inc. announced its unaudited financial results for the fourth quarter and full year of 2025. Q4 net revenue reached RMB 1.1413 billion, a 40.3% year-over-year increase, while full-year net revenue grew 44.0% to RMB 3.9589 billion.
Mar.13 by 2FIRSTS.ai
Special Report|FDA Revises Device Name in Glas Vape Authorization; Company Signals Optimism on Menthol, Flavored Pods
Special Report|FDA Revises Device Name in Glas Vape Authorization; Company Signals Optimism on Menthol, Flavored Pods
The FDA updated public records on the PMTA authorization of a Glas vape product, renaming “Glas G Device” to “Glas G² Device” and releasing the order letter detailing scientific review and marketing restrictions. Company disclosures suggest the platform may include age-verification technology. If confirmed, Glas G² could be the first vape with device-level age verification to receive an FDA MGO. Glas executives also said menthol and other flavored pods could gain authorization in the future.
Special Report
Mar.14
Scandinavian Tobacco Group to Hold Annual General Meeting on April 15
Scandinavian Tobacco Group to Hold Annual General Meeting on April 15
Scandinavian Tobacco Group A/S has issued notice of its annual general meeting, which will be held on April 15, 2026 at 4:30 p.m. in Copenhagen and will also be available by live webcast.
Mar.25 by 2FIRSTS.ai
Spanish Congress Health Committee Approves Motion to Restrict Vape and Nicotine Pouch Sales to Authorized Channels
Spanish Congress Health Committee Approves Motion to Restrict Vape and Nicotine Pouch Sales to Authorized Channels
Spain’s Congress Health Committee has approved a non-binding motion calling for the sale of vapes, nicotine pouches, and related products to be limited to regulated authorized channels, excluding internet sales and non-specialized stores. The motion was introduced by the Socialist Parliamentary Group and approved after a negotiated text with the Popular Party.
Apr.15 by 2FIRSTS.ai
Altria Announces Nationwide Retail Expansion of on! PLUS Nicotine Pouches
Altria Announces Nationwide Retail Expansion of on! PLUS Nicotine Pouches
Altria Group, Inc. announced the nationwide retail expansion of on! PLUS nicotine pouches, a product manufactured by Helix Innovations LLC, an Altria operating company. The product had already been available through e-commerce and participating retailers in North Carolina, Florida and Texas, began wholesale deliveries on March 16, 2026, and is expected to reach participating retailers nationwide starting March 23, 2026.
Mar.24 by 2FIRSTS.ai
2Firsts Interview with Glas |Why a California ENDS Company Believes Its Age-gated Flavored Vape Could Be Next in Line for FDA Authorization
2Firsts Interview with Glas |Why a California ENDS Company Believes Its Age-gated Flavored Vape Could Be Next in Line for FDA Authorization
As the FDA advances efforts to streamline its PMTA review process, including support for small businesses, expectations are rising that additional product authorizations may follow. Age-verification technology is emerging as a key consideration in future approvals.In this interview, California-based Glas discusses its G2 platform, integrating smartphone-based identity verification, proximity controls and anti-counterfeit systems, and outlines its positioning under the FDA’s PMTA framework.
Mar.02